Which Patient Benefits from Guideline-directed Medical Therapy for Heart Failure and Rate Control versus Rhythm Control in Patients with Congestive Heart Failure and Atrial Fibrillation and What are Those Therapies?
Arrhythmia & Electrophysiology Review · 05.05.2026
DOI: 10.15420/aer.2025.39 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Arrhythmia & Electrophysiology Review, online erschienen am 05.05.2026. Verfasst von Gregory Burkman und 1 weiteren Autor:innen. Beteiligte Einrichtung: Penn State University College of Medicine, Penn State Health, Heart and Vascular Institute, Milton S Hershey Medical Center Hershey, PA, US. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
The management of AF in patients with heart failure is complex and nuanced. This paper explores the potential antiarrhythmic effects of guideline-directed medical therapy for heart failure and reviews the pharmacological and ablative treatments for AF. Heart failure with reduced ejection fraction is discussed separately from heart failure with preserved ejection fraction. Treatment recommendations for each heart failure subtype are given.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Penn State University College of Medicine, Penn State Health, Heart and Vascular Institute, Milton S Hershey Medical Center Hershey, PA, US.
ORCID-Profile: Gregory Burkman, Gerald V Naccarelli
Zitieren
APA
Burkman, G., & Naccarelli, G. V. (2026). Which Patient Benefits from Guideline-directed Medical Therapy for Heart Failure and Rate Control versus Rhythm Control in Patients with Congestive Heart Failure and Atrial Fibrillation and What are Those Therapies?. Arrhythmia & Electrophysiology Review. https://doi.org/10.15420/aer.2025.39
Vancouver
Burkman G, Naccarelli GV. Which Patient Benefits from Guideline-directed Medical Therapy for Heart Failure and Rate Control versus Rhythm Control in Patients with Congestive Heart Failure and Atrial Fibrillation and What are Those Therapies?. Arrhythmia & Electrophysiology Review. 2026. doi:10.15420/aer.2025.39
BibTeX
@article{Burkman2026,
author = {Burkman, Gregory and Naccarelli, Gerald V},
title = {Which Patient Benefits from Guideline-directed Medical Therapy for Heart Failure and Rate Control versus Rhythm Control in Patients with Congestive Heart Failure and Atrial Fibrillation and What are Those Therapies?},
journal = {Arrhythmia & Electrophysiology Review},
year = {2026},
doi = {10.15420/aer.2025.39}
}
EUVIMED